145 related articles for article (PubMed ID: 16926283)
1. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
[TBL] [Abstract][Full Text] [Related]
2. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
3. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
[TBL] [Abstract][Full Text] [Related]
4. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).
Nagel S; Kaufmann M; Drexler HG; MacLeod RA
Cancer Res; 2003 Sep; 63(17):5329-34. PubMed ID: 14500364
[TBL] [Abstract][Full Text] [Related]
5. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
Bernard OA; Busson-LeConiat M; Ballerini P; Mauchauffé M; Della Valle V; Monni R; Nguyen Khac F; Mercher T; Penard-Lacronique V; Pasturaud P; Gressin L; Heilig R; Daniel MT; Lessard M; Berger R
Leukemia; 2001 Oct; 15(10):1495-504. PubMed ID: 11587205
[TBL] [Abstract][Full Text] [Related]
6. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).
Berger R; Dastugue N; Busson M; Van Den Akker J; Pérot C; Ballerini P; Hagemeijer A; Michaux L; Charrin C; Pages MP; Mugneret F; Andrieux J; Talmant P; Hélias C; Mauvieux L; Lafage-Pochitaloff M; Mozziconacci MJ; Cornillet-Lefebvre P; Radford I; Asnafi V; Bilhou-Nabera C; Nguyen Khac F; Léonard C; Speleman F; Poppe B; Bastard C; Taviaux S; Quilichini B; Herens C; Grégoire MJ; Cavé H; Bernard OA;
Leukemia; 2003 Sep; 17(9):1851-7. PubMed ID: 12970786
[TBL] [Abstract][Full Text] [Related]
7. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
[TBL] [Abstract][Full Text] [Related]
8. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia.
Su XY; Busson M; Della Valle V; Ballerini P; Dastugue N; Talmant P; Ferrando AA; Baudry-Bluteau D; Romana S; Berger R; Bernard OA
Genes Chromosomes Cancer; 2004 Nov; 41(3):243-9. PubMed ID: 15334547
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.
Cavé H; Suciu S; Preudhomme C; Poppe B; Robert A; Uyttebroeck A; Malet M; Boutard P; Benoit Y; Mauvieux L; Lutz P; Méchinaud F; Grardel N; Mazingue F; Dupont M; Margueritte G; Pages MP; Bertrand Y; Plouvier E; Brunie G; Bastard C; Plantaz D; Vande Velde I; Hagemeijer A; Speleman F; Lessard M; Otten J; Vilmer E; Dastugue N;
Blood; 2004 Jan; 103(2):442-50. PubMed ID: 14504110
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).
Hansen-Hagge TE; Schäfer M; Kiyoi H; Morris SW; Whitlock JA; Koch P; Bohlmann I; Mahotka C; Bartram CR; Janssen JW
Leukemia; 2002 Nov; 16(11):2205-12. PubMed ID: 12399963
[TBL] [Abstract][Full Text] [Related]
11. High incidence of Hox11L2 expression in children with T-ALL.
Mauvieux L; Leymarie V; Helias C; Perrusson N; Falkenrodt A; Lioure B; Lutz P; Lessard M
Leukemia; 2002 Dec; 16(12):2417-22. PubMed ID: 12454747
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion.
Oliveira JL; Kumar R; Khan SP; Law ME; Erickson-Johnson M; Oliveira AM; Ketterling RP; Dogan A
Pediatr Blood Cancer; 2011 Mar; 56(3):467-9. PubMed ID: 21225930
[TBL] [Abstract][Full Text] [Related]
13. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
14. NUP214-ABL1 amplification in t(5;14)/HOX11L2-positive ALL present with several forms and may have a prognostic significance.
Ballerini P; Busson M; Fasola S; van den Akker J; Lapillonne H; Romana SP; Marynen P; Bernard OA; Landman-Parker J; Berger R
Leukemia; 2005 Mar; 19(3):468-70. PubMed ID: 15674415
[No Abstract] [Full Text] [Related]
15. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
[TBL] [Abstract][Full Text] [Related]
16. Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.
Kurosawa N; Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Isobe M
PLoS One; 2013; 8(1):e55147. PubMed ID: 23383087
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia.
Nicci C; Ottaviani E; Luatti S; Grafone T; Tonelli M; Motta MR; Malagola M; Marzocchi G; Martinelli G; Baccarani M; Testoni N
Leukemia; 2005 Mar; 19(3):470-2. PubMed ID: 15674421
[No Abstract] [Full Text] [Related]
18. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
Przybylski GK; Dik WA; Wanzeck J; Grabarczyk P; Majunke S; Martin-Subero JI; Siebert R; Dölken G; Ludwig WD; Verhaaf B; van Dongen JJ; Schmidt CA; Langerak AW
Leukemia; 2005 Feb; 19(2):201-8. PubMed ID: 15668700
[TBL] [Abstract][Full Text] [Related]
20. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
